
TIGRIS TRIAL RESULTS
Positive topline results from the Tigris trial have just been announced. This phase 3 follow-on sponsored study evaluates the use of Polymyxin B Hemoadsorption (“PMX” – Toray Medical Inc, Tokyo) in a randomized clinical trial of adults treated for Endotoxic Septic Shock (ESS) selected using the Endotoxin Activity Assay (EAA – Spectral Medical Inc., Toronto).